A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies
Open Access
- 11 September 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 26 (23) , 4657-4667
Abstract
Joubert syndrome (JBTS) is the archetypal ciliopathy caused by mutation of genes encoding ciliary proteins leading to multi-system phenotypes, including a cerebello-retinal-renal syndrome. JBTS is genetically heterogeneous, however mutations in CEP290 are a common underlying cause. The renal manifestation of JBTS is a juvenile-onset cystic kidney disease, known as nephronophthisis, typically progressing to end-stage renal failure within the first two decades of life, thus providing a potential window for therapeutic intervention. In order to increase understanding of JBTS and its associated kidney disease and to explore potential treatments, we conducted a comprehensive analysis of primary renal epithelial cells directly isolated from patient urine (human urine-derived renal epithelial cells, hURECs). We demonstrate that hURECs from a JBTS patient with renal disease have elongated and disorganized primary cilia and that this ciliary phenotype is specifically associated with an absence of CEP290 protein. Treatment with the Sonic hedgehog (Shh) pathway agonist purmorphamine or cyclin-dependent kinase inhibition (using roscovitine and siRNA directed towards cyclin-dependent kinase 5) ameliorated the cilia phenotype. In addition, purmorphamine treatment was shown to reduce cyclin-dependent kinase 5 in patient cells, suggesting a convergence of these signalling pathways. To our knowledge, this is the most extensive analysis of primary renal epithelial cells from JBTS patients to date. It demonstrates the feasibility and power of this approach to directly assess the consequences of patient-specific mutations in a physiologically relevant context and a previously unrecognized convergence of Shh agonism and cyclin-dependent kinase inhibition as potential therapeutic targets.Keywords
Funding Information
- Medical Research Council (MR/M012212/1)
This publication has 46 references indexed in Scilit:
- Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response SignalingCell, 2012
- TCTN3 Mutations Cause Mohr-Majewski SyndromeThe American Journal of Human Genetics, 2012
- Mainzer-Saldino Syndrome Is a Ciliopathy Caused by IFT140 MutationsThe American Journal of Human Genetics, 2012
- Hedgehog-Gli Pathway Activation during Kidney FibrosisThe American Journal of Pathology, 2012
- Arl13b regulates ciliogenesis and the dynamic localization of Shh signaling proteinsMolecular Biology of the Cell, 2011
- Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3Human Molecular Genetics, 2009
- Pleiotropic Effects of CEP290 (NPHP6) Mutations Extend to Meckel SyndromeThe American Journal of Human Genetics, 2007
- Mutations in the CEP290 (NPHP6) Gene Are a Frequent Cause of Leber Congenital AmaurosisThe American Journal of Human Genetics, 2006
- Purmorphamine activates the Hedgehog pathway by targeting SmoothenedNature Chemical Biology, 2005
- A motility in the eukaryotic flagellum unrelated to flagellar beating.Proceedings of the National Academy of Sciences, 1993